Domain/tracer items | Medical centres (n = 112) | Peripheral health centres (n = 546) | ||
---|---|---|---|---|
Availability (%) | Posterior inclusion probability2 (%) | Availability (%) | Posterior inclusion probability (%) | |
General service | ||||
Basic amenities1 | 39 (34.8) | 6 (1.1) | ||
Power (electric or solar device) | 86 (76.8) | 8.5 | 362 (66.3) | 21.4 |
Improved water source inside or within the ground of the facility | 110 (98.2) | −3 | 476 (87.2) | 60.9 |
Room with auditory and visual privacy for patient consultations | 81 (72.3) | 100 | 284 (52.0) | 39.2 |
Access to adequate sanitation facilities for clients | 109 (97.3) | – | 519 (95.1) | – |
Communication equipment (phone or SW radio) | 111 (99.1) | – | 535 (98.0) | – |
Facility has access to computer with E-mail/Internet access | 56 (50.0) | 6.9 | 10 (1.8) | – |
Emergency transportation | 106 (94.6) | 61.7 | 515 (94.3) | 88.0 |
Basic equipment | 72 (64.2) | 264 (48.4) | ||
Adult scale | 108 (96.4) | – | 527 (96.5) | – |
Child scale | 82 (73.2) | 13.2 | 428 (78.4) | 15.1 |
Thermometer | 112 (100) | – | 544 (99.6) | – |
Stethoscope | 112 (100) | – | 540 (98.9) | – |
Blood pressure apparatus | 109 (97.3) | – | 533 (97.6) | – |
Light source | 92 (82.1) | 100 | 349 (63.9) | 16.2 |
Standard precautions for infection prevention | 52 (46.4) | 223 (40.8) | ||
Safe final disposal of sharp materials | 85 (75.9) | 84.7 | 422 (77.3) | 28.2 |
Safe final disposal of infectious wastes | 82 (73.2) | 62.9 | 336 (61.5) | 18.2 |
Appropriate storage of sharp waste | 110 (98.2) | – | 535 (98.0) | – |
Appropriate storage of infectious waste | 103 (92.0) | 85.3 | 494 (90.5) | 50.8 |
Disinfectant | 111 (99.1) | – | 544 (99.6) | – |
Single use (standard disposable or auto-disable syringes) | 111 (99.1) | – | 543 (99.5) | – |
Soap and running water or alcohol based hand rub | 105 (93.8) | 33.6 | 518 (94.9) | 99.2 |
Latex gloves | 100 (89.9) | 56.1 | 499 (91.4) | 99.3 |
Guidelines for standard precautions | 98 (87.5) | 98.3 | 469 (85.9) | 21.2 |
Diagnostic capacity | 37 (33.0) | 3 (0.6) | ||
Haemoglobin | 72 (64.3) | 100 | 9 (1.7) | – |
Blood glucose | 50 (44.6) | 48.2 | 6 (1.1) | – |
Malaria diagnostic capacity | 101 (90.2) | 17.5 | 467 (85.5) | 21.3 |
Urine dipstick-protein | 103 (92.0) | 49.0 | 501 (91.8) | 50.1 |
Urine dipstick-glucose | 104 (92.9) | 80.6 | 491 (89.9) | 31.4 |
HIV diagnostic capacity | 106 (94.6) | 32.9 | 512 (93.8) | 39.8 |
Urine test for pregnancy | 96 (85.7) | 26.0 | 412 (75.5) | 42.3 |
Essential medicines | 2 (0.1) | 0 (0) | ||
Amoxicillin tablet | 101 (90.2) | 40.6 | 523 (95.8) | – |
Ampicillin for inject | 104 (92.9) | 21.7 | 519 (95.1) | – |
Gentamicin injectable | 101 (90.2) | 77.7 | 472 (86.5) | 30.3 |
Oxytocin injectable | 98 (87.5) | 100 | 502 (91.9) | 77.8 |
Amoxicillin dispersible | 94 (83.9) | 10.6 | 475 (87.0) | 20.1 |
Oral rehydration solution (ORS) | 95 (84.8) | 16.8 | 476 (87.2) | 20.3 |
Zinc | 77 (68.8) | 100 | 418 (76.6) | 14.9 |
Aspirin | 94 (83.9) | 100 | 377 (69.1) | 19.6 |
Magnesium sulfate | 78 (69.6) | 100 | 121 (22.2) | 20.9 |
Amlodipine | 25 (22.3) | 100 | 12 (2.2) | – |
Enalapril | 20 (17.9) | 26.1 | 6 (1.1) | – |
Insulin injectable | 8 (7.1) | 35.9 | 5 (0.9) | – |
Betablockers | 20 (17.9) | 100 | 8 (1.5) | – |
Beclomethasone inhaler | 14 (12.5) | 100 | 9 (1.7) | – |
Ceftriaxone injection | 103 (92.0) | 93.8 | 492 (90.1) | 58.4 |
Thiazidic | 25 (22.3) | 14.2 | 41 (7.5) | 50.6 |
Glibenclamide tablet | 39 (34.8) | 100 | 10 (1.8) | – |
Metformin | 41 (36.6) | 22.9 | 9 (1.7) | – |
Omeprazole | 65 (58.0) | 10.1 | 110 (20.2) | 20.2 |
Salbutamol inhaler | 86 (76.8) | 63.3 | 288 (52.8) | 24.9 |
Carbamazepine | 28 (25.0) | 69.9 | 0 (0.0) | – |
Haloperidol | 27 (24.1) | 96.6 | 0 (0.0) | – |
Simvastatin | 4 (3.6) | – | ||
Fluoxetin | 3 (2.7) | – | – | |
Malaria-specific service | ||||
Staff and guidelines | 41 (45.5) | 313 (57.7) | ||
Guidelines for diagnosis and treatment of malaria | 105 (93.8) | 22.4 | 536 (98.2) | – |
Guidelines for intermittent preventive treatment | 75 (67.0) | 13.0 | 481 (88.1) | 31.1 |
Staff trained in malaria diagnosis and treatment | 79 (70.5) | 97.5 | 453 (83.0) | 40.9 |
Staff trained in intermittent preventive treatment | 74 (66.1) | 100 | 370 (67.8) | 58.9 |
Diagnostics | 101 (90.2) | 467 (85.5) | ||
Malaria diagnostic capacity (rapid diagnostic test/thin blood film) | 101 (90.2) | 17.5 | 467 (85.5) | 21.3 |
Medicines and commodities | 21 (18.8) | 172 (31.5) | ||
First-line antimalarial in stock (artemether+lumefantrine, artesunate+amodiaqune) | 99 (88.4) | 58.8 | 526 (96.3) | – |
Paracetamol cap/tab | 104 (92.9) | 100 | 418 (76.2) | 34.6 |
Intermittent preventive treatment of malaria in pregnancy (IPTp) drug (sulfadoxine pyrimethamine) | 62 (55.4) | 28.4 | 356 (65.2) | 17.1 |
ITNs | 29 (25.9) | 73.2 | 185 (33.9) | 26.2 |